OpenAlex
PricingAboutJobs
Log inGet started
Work

Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape

HTML

Year: 2022
Type: article
Source: Nature Reviews Drug Discovery
DOI: 10.1038/d41573-022-00030-4
Authors: Samik Upadhaya, Svetoslav T. Neftelinov, Jeffrey Hodge, Jay Campbell
Institutions: Cancer Research Institute, IQVIA (United States)
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: PD-1 inhibitors, PD-L1 inhibitors, immune checkpoint inhibitors, cancer immunotherapy, clinical trial design, immune-related adverse events, biomarkers, predictive biomarkers
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4211168024
FWCI: 20.67
Cites:
Cited by: 224
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security